1199797-92-6
1199797-92-6
Chemical Structure
CDFI
- CAS No.: 1199797-92-6
- Formula:C28H28ClFN2
- Molecular Weight:446.99
InChIKey: KRLGPLURVLJNOH-UHFFFAOYSA-N
SMILES: FC1=CC2=C(NC(C3=C(Cl)C=CC=C3)=C2C4CCN(CC4)CC5=C(C)C(C)=CC=C5)C=C1
Biological Activity: CDFI is an antibacterial agent that targets the bacterial cell wall. CDFI inhibits the lipid II flippase MurJ in the peptidoglycan synthesis pathway. CDFI can be used for the research of Staphylococcus aureus infections[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CDFI | 99.43% | CDFI is an antibacterial agent that targets the bacterial cell wall. CDFI inhibits the lipid II flippase MurJ in the peptidoglycan synthesis pathway. CDFI can be used for the research of Staphylococcus aureus infections. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Fernandes PB, et al. Revisiting the Role of VraTSR in Staphylococcus aureus Response to Cell Wall-Targeting Antibiotics. Bacteriology. 2022 Jul 13;204:e00162-22.
- [2]. Dhanda G, et al. Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance. ACS Omega. 2023 Mar 14;8(12):10757-10783. [Content Brief]
Keywords
